Xeloda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

A Study of DB-1303 vs Investigator's Choice Chemotherapy in Metastatic Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: DB-1303;   Drug: Capecitabine;   Drug: Paclitaxel;   Drug: Nab-paclitaxel Sponsor:   DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Condition:   Rectal Neoplasms Interventions:   Drug: Tislelizumab;   Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: SIB-IMRT;   Radiation: IMRT Sponsor:   Yong Zhang,MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials